CLINICAL_TRIALS ClinicalTrials.gov record update

Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis: an Observational Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT07235644
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:57.403816+00:00
Published At: 2025-11-19T00:00:00+00:00
Record Updated At: 2025-11-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["MS (Multiple Sclerosis)", "Multiple Sclerosis (MS) - Relapsing-remitting", "Multiple Sclerosis (Relapsing Remitting)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-11-19"
protocolSection.identificationModule.nctId: "NCT07235644"
protocolSection.identificationModule.officialTitle: "Comparison of Efficacy and Safety in Patients Switching From MabThera\u00ae to Rixathon\u00ae in Relapsing-Remitting Multiple Sclerosis: an Observational Study"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.